Research Article
Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
Table 4
Correlation between the expression of miRNA and different clinical characteristics.
| Characteristics | let-7c-5p | let-7d-5p | miR-140-3p | miR-185-5p | miR-425-5p | r | | r | | r | | r | | r | |
| Hemoglobin | 0.107 | 0.469 | 0.222 | 0.129 | 0.306 | 0.034 | 0.325 | 0.027 | 0.279 | 0.058 | Neutrophil | 0.038 | 0.802 | 0.020 | 0.892 | −0.077 | 0.609 | 0.044 | 0.773 | 0.000 | 0.998 | Platelet | 0.115 | 0.440 | 0.106 | 0.477 | 0.256 | 0.083 | 0.259 | 0.086 | 0.296 | 0.046 | Creatinine | −0.309 | 0.033 | −0.227 | 0.120 | −0.527 | 0.000 | −0.500 | 0.000 | −0.524 | 0.000 | Ca | −0.140 | 0.341 | −0.076 | 0.608 | 0.034 | 0.821 | −0.013 | 0.930 | 0.076 | 0.609 | β2-Microglobulin | −0.311 | 0.031 | −0.412 | 0.004 | −0.437 | 0.002 | −0.483 | 0.001 | −0.453 | 0.001 | ALP | −0.097 | 0.513 | −0.088 | 0.551 | 0.096 | 0.515 | 0.078 | 0.606 | 0.044 | 0.771 | LDH | −0.032 | 0.828 | 0.017 | 0.907 | −0.201 | 0.172 | −0.140 | 0.354 | −0.197 | 0.185 | VEGF | −0.001 | 0.996 | −0.147 | 0.377 | −0.106 | 0.526 | −0.152 | 0.370 | −0.105 | 0.529 | IL-6 | −0.426 | 0.009 | −0.244 | 0.146 | −0.393 | 0.016 | −0.420 | 0.011 | −0.518 | 0.001 | IL-6R | −0.206 | 0.215 | −0.091 | 0.585 | −0.038 | 0.823 | −0.026 | 0.877 | −0.096 | 0.568 | TRAP5B | −0.070 | 0.681 | 0.075 | 0.661 | −0.057 | 0.738 | 0.038 | 0.828 | 0.022 | 0.897 | β-CTX | −0.326 | 0.047 | −0.334 | 0.044 | −0.346 | 0.036 | −0.349 | 0.037 | −0.415 | 0.011 | 25-OH-VD | 0.124 | 0.465 | 0.128 | 0.450 | 0.177 | 0.296 | 0.248 | 0.144 | 0.237 | 0.158 | BAP | 0.010 | 0.954 | 0.075 | 0.660 | −0.058 | 0.731 | 0.058 | 0.737 | 0.090 | 0.596 | BM PC (%) | −0.311 | 0.031 | −0.412 | 0.004 | −0.437 | 0.002 | −0.483 | 0.001 | −0.453 | 0.001 |
|
|
; ; r, correlation; IL-6, interleukin-6; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; VEGF, vascular endothelial growth factor; IL-6R, interleukin-6 receptor; TRAP5B, tartrate-resistant acid phosphatase; β-CTX, Β-type I collagen carboxy-terminal peptide; 25-OH-VD, 25-hydroxyvitamin D; BAP, bone alkaline phosphatase; BM PC, bone marrow plasma cells. |